News

Novavax projects $1.025B 2025 revenue framework with focus on partnerships
Explore Novavax's Q1 2025 earnings insights, highlighting raised revenue forecasts, strategic partnerships, and progress toward non-GAAP profitability ...
Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsLuis Sanay - Vice President, Investor ...
Q1 2025 TG Therapeutics Inc Earnings Call
Greetings and welcome to TG Therapeutics first quarter conference call and webcast. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your ...
TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption
TG Therapeutics reports strong Q1 2025 results with $119.7M in BRIUMVI sales, raises 2025 revenue guidance, and eyes pivotal trials for ...